Blog
BTOG 2019 blogs by first time attendees
February 2019 Four first time attendees at BTOG 2019 kindly took the time to write a blog about their experience and thoughts on the conference....
Treating tobacco addiction improves the outcomes of patients with lung cancer
December 2018 By Sanjay Agrawal, Consultant Respiratory Intensivist As specialists with an interest in thoracic oncology, we want our...
PACIFIC Trial: Adjuvant Immunotherapy Improves Overall Survival (OS) in Stage III NSCLC
November 2018 By Fiona McDonald, Consultant Thoracic Clinical Oncologist The plenary session at WCLC 2018 in Toronto and parallel NEJM...
WCLC Highlights
October 2018 By James Spicer, Professor of Experimental Cancer Medicine and Consultant in Medical Oncology ALTA1: brigatinib vs crizotinib in...
NELSON screening study gives boost to CT screening in Europe
September 2018 By Dr Matthew Callister, Consultant Respiratory Physician CT screening in Europe took a leap forward this week with the publication...
Immunotherapy for locally-advanced lung cancer one step nearer
August 2018 By Tom Newsom-Davis, Consultant Oncologist On 26th July 2018 one of the European Medicines Agency (EMA) committees recommended that the...
NICE approves Alectinib as first line treatment for ALK-translocated NSCLC
July 2018 By Tom Newsom-Davis, Consultant Oncologist NICE has just approved Alectinib as first line treatment for ALK-translocated NSCLC....